Liu, X., Wang, H., Liang, Y., Cong, J., Wang, L. (2025). CD19/CD22 bispecific CAR-t cell therapy for relapsed/refractory large b-cell lymphoma: A prospective, single-arm, single-center, phase 2 clinical trial. Blood. https://doi.org/10.1182/blood-2025-570